Comparer des méthodes

	Analyse Coûts-Bénéfices (ACB)	Analyse coût-efficacité (ACE)
Domaine	Économie de la santé	Économie de la santé
Famille	Process / pipeline	Process / pipeline
Année d'origine	1970s	1984
Auteur d'origine	Boardman, Greenberg, and colleagues (welfare economics)	Drummond & Stoddart (Health Economics Research Group, McMaster University)
Type	Method	Method
Source fondatrice	Boardman, A. E., Greenberg, D. H., Vining, A. R., & Weimer, D. L. (2018). Cost-Benefit Analysis: Concepts and Practice (5th ed.). Cambridge: Cambridge University Press.	Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.
Alias	CBA, economic appraisal, benefit-cost ratio	CEA, ICER, Incremental Cost-Effectiveness Ratio
Apparentées	5	5
Résumé	Cost-benefit analysis compares the total monetary value of benefits produced by a program against its total monetary costs, reporting net present value (NPV) or benefit-cost ratio (BCR). Rooted in welfare economics and used extensively in public policy (transportation, environmental, education, health), CBA answers the question: 'Is this program worth doing from a societal perspective?' Unlike cost-effectiveness analysis, CBA monetizes both costs and benefits, enabling comparison across disparate program types.	Cost-effectiveness analysis compares the incremental cost per unit of health benefit gained by one intervention relative to a comparator (standard care or best alternative). Developed rigorously in the 1980s by Drummond, Stoddart, and colleagues, CEA is now the standard framework for technology appraisal globally. NICE, HAS, CADTH, and other health technology assessment bodies use CEA to decide which treatments warrant public funding and at what price.